Prosecution Insights
Last updated: April 19, 2026

Johnson, Marcou, Isaacs & Nix, LLC

68 pending office actions • 24 clients

Portfolio Summary

68
Total Pending OAs
20
Final Rejections
48
Non-Final OAs

Client Portfolio (24 clients)

Client (Assignee)Pending OAs
Massachusetts Institute Of Technology 21
Massachusetts Institute Of Technology 10
President and Fellows of Harvard College 7
The United States Department of Health and Human Services 3
Epax Norway AS 2
The Brigham And Women'S Hospital, Inc. 2
Lankem Ltd. 2
President and Fellows of Harvard College 2
DANA-FARBER CANCER INSTITUTE, INC. 2
The General Hospital Corporation 2
River Front Services, Inc. 1
VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. 1
Elaphe Propulsion Technologies, Ltd. 1
Société des Produits Nestlé S.A. 1
DANA-FARBER CANCER INSTITUTE, INC. 1
Ic Targets AS 1
The Broad Institute, Inc. 1
Arteria Technology, Inc. 1
Simon Hanl 1
The Children's Hospital of Philadelphia 1
The Regents of the University of California 1
California Institute Of Technology 1
Oxford University Innovation Limited 1
The Brigham And Women'S Hospital, Inc. 1

Pending Office Actions

App #TitleClientExaminerArt UnitStatusFiled
19390128 Untitled Massachusetts Institute Of Technology WEHBE, ANNE MARIE SABRINA 1634 Non-Final OA
19390070 Untitled Massachusetts Institute Of Technology CHESTNUT, BARRY A 1672 Non-Final OA
18891923 Untitled River Front Services, Inc. HAYES, BRET C 3641 Non-Final OA
19329060 VERY LONG CHAIN FATTY ACIDS FOR TREATMENT AND ALLEVIATION OF DISEASES Epax Norway AS KUCKLA, ANNA GRACE 1626 Non-Final OA Sep 15, 2025
18990537 BIFUNCTIONAL MOLECULES FOR SELECTIVE MODIFICATION OF TARGET SUBSTRATES The Brigham And Women'S Hospital, Inc. VISHNYAKOVA, ELENA VLADIMIROVNA 1691 Final Rejection Dec 20, 2024
18965935 NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS Massachusetts Institute Of Technology RYAN, DOUGLAS CHARLES 1635 Non-Final OA Dec 02, 2024
18628213 NANOPOROUS ALLOYS VIRGINIA TECH INTELLECTUAL PROPERTIES, INC. WANG, XIAOBEI 1784 Non-Final OA Apr 05, 2024
18688206 STATOR WITH PERMANENT PROTECTIVE BARRIER SEALING Elaphe Propulsion Technologies, Ltd. ANDREWS, MICHAEL 2834 Non-Final OA Feb 29, 2024
18430788 MULTI-EFFECTOR CRISPR BASED DIAGNOSTIC SYSTEMS President and Fellows of Harvard College PAGE, BRENT T 1663 Non-Final OA Feb 02, 2024
18576909 METHODS FOR DIFFERENTIATING AND SCREENING STEM CELLS Massachusetts Institute Of Technology WESTON, ALYSSA G 1633 Non-Final OA Jan 05, 2024
18574816 BIFIDOBACTERIUM LONGUM TRANSITIONAL MICROORGANISMS, COMPOSITIONS AND USES THEREOF Société des Produits Nestlé S.A. DICKENS, AMELIA NICOLE 1645 Non-Final OA Dec 28, 2023
18541680 METHODS AND COMPOSITIONS FOR PREDICTING AND PREVENTING RELAPSE OF ACUTE LYMPHOBLASTIC LEUKEMIA DANA-FARBER CANCER INSTITUTE, INC. DAVIS, BRIAN J 1614 Non-Final OA Dec 15, 2023
18566924 MANGANESE-ENHANCED MAGNETIC RESONANCE IMAGING Ic Targets AS LIU, CHU CHUAN 3791 Non-Final OA Dec 04, 2023
18387415 WATER TREATMENT SYSTEM WITH RETRIEVABLE MOUNTING FRAME ASSEMBLY FOR DIFFUSORS Unknown GONZALEZ, MADELINE 1773 Non-Final OA Nov 06, 2023
18501637 PHASED GENOME SCALE EPIGENETIC MAPS AND METHODS FOR GENERATING MAPS The Broad Institute, Inc. KAPUSHOC, STEPHEN THOMAS 1683 Non-Final OA Nov 03, 2023
18488197 DELIVERY, USE AND THERAPEUTIC APPLICATIONS OF CRISPR SYSTEMS AND COMPOSITIONS FOR GENOME EDITING AS TO HEMATOPOIETIC STEM CELLS (HSCs) Massachusetts Institute Of Technology MOLOYE, TITILAYO 1632 Final Rejection Oct 17, 2023
18285280 METHODS, DEVICES, AND SYSTEMS FOR MAMMALIAN BODY TEMPERATURE MANIPULATION Arteria Technology, Inc. NIA, ALIREZA 3786 Non-Final OA Oct 02, 2023
18283520 TOW ELEMENT AND METHOD FOR TOWING A BICYCLE WITH A TOW LIFT Simon Hanl MCCARRY JR, ROBERT J 3615 Non-Final OA Sep 22, 2023
18280547 METHODS OF PREDICTING RESPONSE TO ANTI-TNF BLOCKADE IN INFLAMMATORY BOWEL DISEASE The Children's Hospital of Philadelphia GAMETT, DANIEL C 1647 Non-Final OA Sep 06, 2023
18277904 SURFACTANT COMPOSITIONS Lankem Ltd. OGDEN JR, NECHOLUS 1761 Non-Final OA Aug 18, 2023
18276471 NUCLEASE-GUIDED NON-LTR RETROTRANSPOSONS AND USES THEREOF Massachusetts Institute Of Technology SULLIVAN, STEPHANIE LAUREN 1635 Non-Final OA Aug 09, 2023
18273579 MODULATION OF A PATHOGENIC PHENOTYPE IN TH1 CELLS The Regents of the University of California RAHMAN, MASUDUR 1633 Non-Final OA Jul 21, 2023
18272158 COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL Massachusetts Institute Of Technology HUDSON, AMY ROSE 1636 Non-Final OA Jul 13, 2023
18216135 COMPOSITION AND METHOD Lankem Ltd. FEELY, MICHAEL J 1766 Non-Final OA Jun 29, 2023
18270131 CROSS-NEUTRALIZING SARS-COV2 ANTIBODIES California Institute Of Technology JADHAO, SAMADHAN JAISING 1672 Non-Final OA Jun 28, 2023
18334074 TYPE VI CRISPR ORTHOLOGS AND SYSTEMS President and Fellows of Harvard College KONOPKA, CATHERINE ANNE 1635 Non-Final OA Jun 13, 2023
18249865 NUCLEIC ACID-GUIDED NUCLEASES AND USE THEREOF Massachusetts Institute Of Technology EBBINGHAUS, BRIANA NOEL 1632 Non-Final OA Apr 20, 2023
18032868 REPROGRAMMABLE ISCB NUCLEASES AND USES THEREOF Massachusetts Institute Of Technology SU-TOBON, QIWEN NMN 1636 Non-Final OA Apr 20, 2023
18032220 METHODS AND COMPOSITIONS FOR DIFFERENTIATING STEM CELLS The Brigham And Women'S Hospital, Inc. HEITMEIER, KENDALL NICOLE 1621 Non-Final OA Apr 17, 2023
18248199 HELITRON MEDIATED GENETIC MODIFICATION Massachusetts Institute Of Technology LIPPOLIS, ALEXANDRA ROSE 1637 Non-Final OA Apr 06, 2023
18030324 T-DNA MEDIATED GENETIC MODIFICATION Massachusetts Institute Of Technology SU-TOBON, QIWEN NMN 1636 Non-Final OA Apr 05, 2023
18026866 CELL-FREE ANTIBODY ENGINEERING PLATFORM AND NEUTRALIZING ANTIBODIES FOR SARS-COV-2 Massachusetts Institute Of Technology BOESEN, AGNIESZKA 1672 Non-Final OA Mar 17, 2023
17928355 CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS AND METHODS OF USE THEREOF Massachusetts Institute Of Technology STAVROU, CONSTANTINA E 1632 Non-Final OA Nov 29, 2022
17921417 METHOD OF DIAGNOSING A BIOLOGICAL ENTITY, AND DIAGNOSTIC DEVICE Oxford University Innovation Limited ERICKSON, BENNETT S 3683 Final Rejection Oct 26, 2022
17916087 SEQUENCING-BASED POPULATION SCALE SCREENING Massachusetts Institute Of Technology YAMASAKI, ROBERT J 1657 Final Rejection Sep 30, 2022
17802932 ZINC FINGER DEGRADATION DOMAINS DANA-FARBER CANCER INSTITUTE, INC. MULDER, SCOTT EVAN 1656 Non-Final OA Aug 26, 2022
17801815 NOVEL TYPE IV AND TYPE I CRISPR-CAS SYSTEMS AND METHODS OF USE THEREOF Massachusetts Institute Of Technology PENNINGTON, KATIE LEIGH 1634 Non-Final OA Aug 24, 2022
17786168 GENOME EDITING USING REVERSE TRANSCRIPTASE ENABLED AND FULLY ACTIVE CRISPR COMPLEXES Massachusetts Institute Of Technology LEE, JAE W 1656 Final Rejection Jun 16, 2022
17785070 PROGRAMMABLE DNA NUCLEASE-ASSOCIATED LIGASE AND METHODS OF USE THEREOF Massachusetts Institute Of Technology PERSONS, JENNA L 1637 Non-Final OA Jun 14, 2022
17773104 TYPE I-B CRISPR-ASSOCIATED TRANSPOSASE SYSTEMS Massachusetts Institute Of Technology NOAKES, SUZANNE MARIE 1656 Non-Final OA Apr 29, 2022
17771309 METHODS AND COMPOSITIONS FOR HIGH-THROUGHPUT COMPRESSED SCREENING FOR THERAPEUTICS Massachusetts Institute Of Technology NGUYEN, LAM S 2853 Final Rejection Apr 22, 2022
17707951 ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS Massachusetts Institute Of Technology WEHBE, ANNE MARIE SABRINA 1634 Non-Final OA Mar 30, 2022
17761292 NOVEL TYPE VI CRISPR ENZYMES AND SYSTEMS Massachusetts Institute Of Technology MCLEOD, AFRICA MHAIRIE 1635 Non-Final OA Mar 17, 2022
17642541 ENGINEERED ADENO-ASSOCIATED VIRUS CAPSIDS Massachusetts Institute Of Technology WEHBE, ANNE MARIE SABRINA 1634 Non-Final OA Mar 11, 2022
17640016 CRISPR EFFECTOR SYSTEM BASED MULTIPLEX CANCER DIAGNOSTICS DANA-FARBER CANCER INSTITUTE, INC. HOPPE, EMMA RUTH 1683 Final Rejection Mar 03, 2022
17614602 METHODS AND COMPOSITIONS FOR MODULATING IMMUNE RESPONSES Massachusetts Institute Of Technology PARKIN, JEFFREY S 1671 Final Rejection Nov 29, 2021
17495219 CRISPR EFFECTOR SYSTEM BASED DIAGNOSTICS President and Fellows of Harvard College LEITH, NANCY J 1636 Non-Final OA Oct 06, 2021
17600799 METHODS AND COMPOSITIONS FOR CELL THERAPY The Brigham And Women'S Hospital, Inc. JOHNSON, ALLISON MARIE 1638 Non-Final OA Oct 01, 2021
17439063 CRISPR EFFECTOR SYSTEM BASED MULTIPLEX DIAGNOSTICS President and Fellows of Harvard College SISSON, BRADLEY L 1682 Final Rejection Sep 14, 2021
17311600 VERY LONG CHAIN FATTY ACID COMPOSITIONS Epax Norway AS WHITE, DAWANNA SHAR-DAY 1627 Final Rejection Jun 07, 2021
17294179 CRISPR SYSTEM BASED DROPLET DIAGNOSTIC SYSTEMS AND METHODS The General Hospital Corporation GIAMMONA, FRANCESCA FILIPPA 1681 Non-Final OA May 14, 2021
17273999 NUCLEIC ACID ASSEMBLIES FOR USE IN TARGETED DELIVERY Massachusetts Institute Of Technology SMALL, KATHERINE R 1633 Final Rejection Mar 05, 2021
17264340 NOVEL CRISPR ENZYMES AND SYSTEMS President and Fellows of Harvard College STEADMAN, DAVID J 1656 Non-Final OA Jan 29, 2021
17254886 CRISPR DOUBLE NICKASE BASED AMPLIFICATION COMPOSITIONS, SYSTEMS, AND METHODS President and Fellows of Harvard College GREENE, CAROLYN LEE 1681 Non-Final OA Dec 22, 2020
16973061 CRISPR EFFECTOR SYSTEM BASED AMPLIFICATION METHODS, SYSTEMS, AND DIAGNOSTICS President and Fellows of Harvard College RAMIREZ, DELIA M 1652 Final Rejection Dec 08, 2020
17085937 BACTERIAL DEFENSE SYSTEMS AND METHODS OF IDENTIFYING THEREOF Massachusetts Institute Of Technology RYAN, DOUGLAS CHARLES 1635 Non-Final OA Oct 30, 2020
17065504 DESIGNING SENSITIVE, SPECIFIC, AND OPTIMALLY ACTIVE BINDING MOLECULES FOR DIAGNOSTICS AND THERAPEUTICS Massachusetts Institute Of Technology STRIEGEL, THEODORE CHARLES 1685 Final Rejection Oct 07, 2020
16936197 FUNCTIONALIZED SOLID SUPPORT Massachusetts Institute Of Technology BUNKER, AMY M 1684 Non-Final OA Jul 22, 2020
16954032 CAS12A SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED RNA BASE EDITING Massachusetts Institute Of Technology HUTSON, RICHARD G 1652 Non-Final OA Jun 15, 2020
16756134 SYSTEMS, METHODS, AND COMPOSITIONS FOR TARGETED NUCLEIC ACID EDITING President and Fellows of Harvard College STEADMAN, DAVID J 1656 Non-Final OA Apr 15, 2020
16820590 NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS Massachusetts Institute Of Technology DACE DENITO, ALEXANDRA GERALDINE 1636 Final Rejection Mar 16, 2020
16632332 COMPOSITIONS AND METHODS FOR TREATING INFLAMMATORY BOWEL DISEASES The General Hospital Corporation STAVROU, CONSTANTINA E 1632 Final Rejection Jan 17, 2020
16631879 NOVEL TYPE VI CRISPR ORTHOLOGS AND SYSTEMS Massachusetts Institute Of Technology SABILA, MERCY HELLEN 1654 Final Rejection Jan 17, 2020
16623799 CRISPR/CAS-CYTIDINE DEAMINASE BASED COMPOSITIONS, SYSTEMS, AND METHODS FOR TARGETED NUCLEIC ACID EDITING President and Fellows of Harvard College NOAKES, SUZANNE MARIE 1656 Final Rejection Dec 18, 2019
16450852 NOVEL CRISPR ENZYMES AND SYSTEMS The United States Department of Health and Human Services RAMIREZ, DELIA M 1652 Final Rejection Jun 24, 2019
16450699 NOVEL CRISPR ENZYMES AND SYSTEMS The United States Department of Health and Human Services RAMIREZ, DELIA M 1652 Non-Final OA Jun 24, 2019
16450825 NOVEL CRISPR ENZYMES AND SYSTEMS The United States Department of Health and Human Services RAMIREZ, DELIA M 1652 Final Rejection Jun 24, 2019
16325892 NOVEL CRISPR ENZYMES AND SYSTEMS Massachusetts Institute Of Technology LEITH, NANCY J 1636 Final Rejection Feb 15, 2019

Managing Johnson, Marcou, Isaacs & Nix, LLC's Patent Prosecution?

IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month